Sex and gender: modifiers of health, disease, and medicine

F Mauvais-Jarvis, NB Merz, PJ Barnes, RD Brinton… - The Lancet, 2020 - thelancet.com
Clinicians can encounter sex and gender disparities in diagnostic and therapeutic
responses. These disparities are noted in epidemiology, pathophysiology, clinical …

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …

AHEM Maas, G Rosano, R Cifkova… - European Heart …, 2021 - academic.oup.com
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

Estradiol, progesterone, immunomodulation, and COVID-19 outcomes

F Mauvais-Jarvis, SL Klein, ER Levin - Endocrinology, 2020 - academic.oup.com
Severe outcomes and death from the novel coronavirus disease 2019 (COVID-19) appear to
be characterized by an exaggerated immune response with hypercytokinemia leading to …

Menopause and women's cardiovascular health: is it really an obvious relationship?

K Ryczkowska, W Adach, K Janikowski… - Archives of medical …, 2022 - pmc.ncbi.nlm.nih.gov
Cardiovascular diseases are common for men and women but there are differences
between the sexes in terms of clinical symptoms, pathophysiology and response to the …

Influence of gender in diabetes mellitus and its complication

T Ciarambino, P Crispino, G Leto… - International journal of …, 2022 - mdpi.com
In medicine, there is growing evidence that gender differences are important and lead to
variations in the pathophysiology and treatment of many diseases with traits that appear to …

Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations

F Mauvais-Jarvis, SH Lindsey - The Journal of Clinical Investigation, 2024 - jci.org
Testosterone (T) and 17β-estradiol (E2) are produced in male and female humans and are
potent metabolic regulators in both sexes. When E2 and T production stops or decreases …

Gender differences in glucose homeostasis and diabetes

F Mauvais-Jarvis - Physiology & behavior, 2018 - Elsevier
Some aspects of glucose homeostasis are regulated differently in males and females. This
review discusses the most fundamental gender differences in glucose homeostasis and …

Body composition and cardiometabolic health across the menopause transition

KL Marlatt, DR Pitynski‐Miller, KM Gavin, KL Moreau… - …, 2022 - Wiley Online Library
Every year, 2 million women reach menopause in the United States, and they may spend
40% or more of their life in a postmenopausal state. In the years immediately preceding …

Risks, benefits, and treatment modalities of menopausal hormone therapy: current concepts

J Mehta, JM Kling, JAE Manson - Frontiers in endocrinology, 2021 - frontiersin.org
Menopausal hormone therapy (HT) prescribing practices have evolved over the last few
decades guided by the changing understanding of the treatment's risks and benefits. Since …

Menopause and diabetes: EMAS clinical guide

R Slopien, E Wender-Ozegowska… - Maturitas, 2018 - Elsevier
Introduction Whether menopause increases the risk of type 2 diabetes mellitus (T2DM)
independently of ageing has been a matter of debate. Controversy also exists about the …